Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse.
J Exp Med (1994) 180 (1): 111–121.
Currently there are no citedby results. Try again later.
